<p>Analyses of primary, secondary and explorative outcomes, service utilization, harms and adverse events.</p
Overview of distinct secondary outcomes in nonrandomised studies, and their impact on hypertension a...
<p>Summary of findings for main outcomes (Analysis I: Random effects model, 14 studies).</p
Primary study characteristics and conclusions of cost-effectiveness analyses.</p
Analyses for primary outcome (readmission to hospital) and secondary outcome (all-cause mortality).<...
<p>Description of the primary outcomes, secondary outcomes and postoperative complications of meta-a...
<p>Primary and secondary outcomes (analysis of carryover effect and period effect).</p
<p>Morbidity and mortality and adverse event incidence rates by study arm—intention-to-treat analysi...
<p>Overview of meta-analyses results for direct effects based on all eligible studies with relevant ...
<p>Analysis of child feeding, morbidity and delivery-related outcomes captured at endpoint by study ...
Occurrence of primary and secondary outcome and their association with NEC in univariable analysis.<...
<p>Conclusions of analyses results for potential secondary effects by trial condition.</p
Results for the two primary outcomes per protocol and intention-to-treat analysis.</p
Overview of the anthropometrics, primary and secondary outcome measures to be collected.</p
<p>Primary analysis: Adjusted hazard ratios of outcomes by NSAID exposure group.</p
<p>Interventions compared, study objectives and main study conclusions of included studies.</p
Overview of distinct secondary outcomes in nonrandomised studies, and their impact on hypertension a...
<p>Summary of findings for main outcomes (Analysis I: Random effects model, 14 studies).</p
Primary study characteristics and conclusions of cost-effectiveness analyses.</p
Analyses for primary outcome (readmission to hospital) and secondary outcome (all-cause mortality).<...
<p>Description of the primary outcomes, secondary outcomes and postoperative complications of meta-a...
<p>Primary and secondary outcomes (analysis of carryover effect and period effect).</p
<p>Morbidity and mortality and adverse event incidence rates by study arm—intention-to-treat analysi...
<p>Overview of meta-analyses results for direct effects based on all eligible studies with relevant ...
<p>Analysis of child feeding, morbidity and delivery-related outcomes captured at endpoint by study ...
Occurrence of primary and secondary outcome and their association with NEC in univariable analysis.<...
<p>Conclusions of analyses results for potential secondary effects by trial condition.</p
Results for the two primary outcomes per protocol and intention-to-treat analysis.</p
Overview of the anthropometrics, primary and secondary outcome measures to be collected.</p
<p>Primary analysis: Adjusted hazard ratios of outcomes by NSAID exposure group.</p
<p>Interventions compared, study objectives and main study conclusions of included studies.</p
Overview of distinct secondary outcomes in nonrandomised studies, and their impact on hypertension a...
<p>Summary of findings for main outcomes (Analysis I: Random effects model, 14 studies).</p
Primary study characteristics and conclusions of cost-effectiveness analyses.</p